Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 18/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 8/20 | 0.40 |
| ▸ | DRD3 | P35462 | 2/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4554540 | 0.75 | ADRB2 (0.51) | ADRB2ADRB1DRD3 | |
| Hydrochloric Acid SCHEMBL4773682 | 0.75 | ADRB2 (0.49) | ADRB2ADRB1 | |
| SCHEMBL3685866 | 0.75 | ADRB2 (0.48) | ADRB2ADRB1DRD3ADRA1D | |
| SCHEMBL3770646 | 0.75 | ADRB2 (0.52) | ADRB2ADRB1DRD3 | |
| SCHEMBL1803587 | 0.72 | ADRB2 (0.51) | ADRB2ADRB1DRD3 | |
| SCHEMBL3589758 | 0.72 | ADRB2 (0.43) | ADRB2ADRB1 | |
| Hydrochloric Acid SCHEMBL1275817 | 0.71 | ADRB2 (0.50) | ADRB2ADRB1DRD3 | |
| SCHEMBL12119358 | 0.70 | ADRB2 (0.54) | ADRB2ADRB1DRD3 | |
| SCHEMBL3685868 | 0.70 | ADRB2 (0.49) | ADRB2ADRB1 | |
| SCHEMBL2814686 | 0.70 | ADRB2 (0.47) | ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010004319-A1 | COMBINATION COMPRISING 6-FLU0R0-N- ((1S, 4S) - 4- (6-FLUORO-2, 4-DI0X0-1- (4'- (PIPERAZIN-1- YLMETHYL) BIPHENYL- 3-YL) -1, 2-DIHYDROPYRIDO [2, 3-D] PYRIMIDIN-3 (4H) - YL) CYCLOHEXYL) IMIDAZO [1,2-A] PYRIDINE -2- CARBOXAMIDE OR A SALT | ASTRAZENECA AB (SE) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009154562-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A 4-HYDROXY-2-OXO-2, 3- DIHYDRO-1, 3-BENZOTHIAZOL-7-YL COMPOUND FOR MODULATION OF BETA2-ADRENORECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2009-12-23 | — | — | WO | disclosed |
| EP-2121642-A1 | 4-HYDR0XY-2-0X0-2, 3 -DIHYDRO- 1, 3-BENZOTHIAZOL- 7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY | AstraZeneca AB (SE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008075026-A1 | 4-HYDR0XY-2-0X0-2, 3 -DIHYDRO- 1, 3-BENZOTHIAZOL- 7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2008-06-26 | — | — | WO | disclosed |